Medical School News and Research

RSS

Irbesartan drug minimizes heart failure complications in patients with atrial fibrillation

In a major international trial, researchers from McMaster University in Canada, found that the hypertension drug irbesartan reduced the risk of heart failure complications and the combination of stroke, other embolic events and transient ischemic events, also known as ministrokes, in patients with atrial fibrillation.

2 Sep 2009

Majority of women depend on family or friend's opinion to decide on breast cancer surgery

About three-quarters of women newly diagnosed with breast cancer have a friend or family member with them at their first visit with a surgeon. And that person plays a significant role in the patient's decision of what type of surgery to have, according to a new study from the University of Michigan Comprehensive Cancer Center.

2 Sep 2009

First AbioCor Total Replacement Heart recipient does not survive

Abiomed, Inc. (NASDAQ: ABMD), has been informed by Mark Anderson, M.D., associate professor of surgery at UMDNJ-Robert Wood Johnson Medical School and chief of the section of cardiac surgery at both the medical school and Robert Wood Johnson University Hospital, that the first patient to receive the commercial AbioCor Total Replacement Heart, died on August 23, 2009, due to post-operative conditions unrelated to the device.

1 Sep 2009

Family and friends play a significant role in breast cancer surgery decision

31 Aug 2009

Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program

Peregrine Pharmaceuticals, Inc., today announced that noted cancer researcher Bruce Chabner, M.D., will serve as a clinical advisor to the company on the design of clinical trials for the bavituximab cancer program.

31 Aug 2009

Results of the Phase II SEPIA-ACS1/ TIMI-42 study presented at the plenary session of the Annual European Society of Cardiology

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy.

31 Aug 2009

Intermediate dosages of otamixaban reduce acute coronary complications

30 Aug 2009

“Next Top Doc” quiz winner to receive the ReachMD $5000.00 Educational Scholarship

ReachMD LLC and ReachMD XM Radio 160, a leading multi-media provider of advanced healthcare education and information, teamed with Dr. Nancy Snyderman, Chief Medical Editor of NBC News, and on staff in the Department of Otolaryngology-Head and Neck Surgery at the University of Pennsylvania, to present the winner of “ReachMD’s Next Top Doc” quiz show with the ReachMD $5000.00 Educational Scholarship.

29 Aug 2009

NIH awards $3.5-million grant to Tay-Sachs Gene Therapy Consortium for research on fatal genetic disorders

In a victory for families who dug into their own pockets to fund new research, the National Institutes of Health has awarded a $3.5-million grant to the Boston-based Tay-Sachs Gene Therapy Consortium to prepare a gene therapy for human clinical trials in a bid to halt the fatal genetic disorder.

28 Aug 2009

Thickening of neck arteries in healthy middle-aged women with feelings of hopelessness

Healthy middle-aged women with feelings of hopelessness appear to experience thickening of the neck arteries, which can be a precursor to stroke, according to new research out of the University of Minnesota Medical School.

27 Aug 2009

Canadian Anesthesiologists' Society responds to reports on Michael Jackson's death

The Canadian Anesthesiologists' Society (CAS) represents the only trained physicians providing anesthetic services in Canada. CAS is responding to reports that Michael Jackson was given a fatal combination of drugs, including the powerful anesthetic propofol, prior to his death on June 25.

27 Aug 2009

Haber’s Electromolecular Propulsion technology offers high molecular separation speeds

Haber, Inc. (“Haber”), (OTC: HABE), a Delaware corporation headquartered in Arlington, Mass., with proprietary technologies in the separations sciences and environmentally friendly processing of gold bearing ores, announced today that it has formed a wholly owned subsidiary incorporated in Delaware called “EMP Diagnostics Inc.” (“EDI”). The business of the new company will focus on the application of Haber’s Electromolecular Propulsion technology (EMP). EMP is a separation technology that achieves unrivaled molecular separation speeds and has other unique capabilities not attainable with electrophoresis or liquid chromatography.

27 Aug 2009

Amateur boxing leads to increased levels of brain damage markers in spinal fluid

A blood test can now be used to detect brain damage in amateur boxers. Deterioration of nerve cells seems to occur even after a two-month break from boxing. This is shown in a new study from the Sahlgrenska Academy, University of Gothenburg, Sweden.

27 Aug 2009

Two-photon microscopy technique tracks calcium levels in mice neurons

For over a century, scientists have been using electrical stimulation to explore and treat the human brain. The technique has helped identify regions responsible for specific neural functions-for instance, the motor cortex and pleasure center-and has been used to treat a variety of conditions from Parkinson's disease to depression.

27 Aug 2009

New president elected for the Foundation for Informed Medical Decision Making non-profit organization

Michael J. Barry, MD, of Massachusetts General Hospital and Harvard Medical School, has been named the new president of the Foundation for Informed Medical Decision Making, the non-profit organization in Boston that has pioneered the creation and use of high quality audio-visual decision aids to enhance patient involvement in their own medical decisions.

26 Aug 2009

Combined therapy for acute leukemia shows promising results

Two of the most powerful approaches to cancer treatment -- a stem cell transplant and an immune system-stimulating vaccine -- appear to reinforce each other in patients with an aggressive, hard-to-control form of leukemia, Dana-Farber Cancer Institute scientists have found.

25 Aug 2009

Low-carbohydrate and high-protein diet increases the risk for atherosclerosis and impaired blood vessels

Even as low-carbohydrate/high-protein diets have proven successful at helping individuals rapidly lose weight, little is known about the diets' long-term effects on vascular health.

25 Aug 2009

Medical students experience life inside nursing home

A novel program in New York gives medical students the chance to experience life as nursing home patients and learn about geriatrics, a field in desperate need of more professionals.

24 Aug 2009

Curemark Founder delivers Industry Keynote address at Epigenomics Conference 2009

Curemark Founder and CEO Dr. Joan Fallon delivered the Industry Keynote address at the Third International Epigenomics, Sequencing 2009 Conference at Harvard Medical School on July 14th

24 Aug 2009

Research study links partial epilepsy to the disruption of brain development during early childhood

A form of partial epilepsy associated with auditory and other sensory hallucinations has been linked to the disruption of brain development during early childhood, according to a study led by researchers at Beth Israel Deaconess Medical Center (BIDMC).

24 Aug 2009

Medical School News and Research

Irbesartan drug minimizes heart failure complications in patients with atrial fibrillation

Majority of women depend on family or friend's opinion to decide on breast cancer surgery

First AbioCor Total Replacement Heart recipient does not survive

Family and friends play a significant role in breast cancer surgery decision

Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program

Results of the Phase II SEPIA-ACS1/ TIMI-42 study presented at the plenary session of the Annual European Society of Cardiology

Intermediate dosages of otamixaban reduce acute coronary complications

“Next Top Doc” quiz winner to receive the ReachMD $5000.00 Educational Scholarship

NIH awards $3.5-million grant to Tay-Sachs Gene Therapy Consortium for research on fatal genetic disorders

Thickening of neck arteries in healthy middle-aged women with feelings of hopelessness

Canadian Anesthesiologists' Society responds to reports on Michael Jackson's death

Haber’s Electromolecular Propulsion technology offers high molecular separation speeds

Amateur boxing leads to increased levels of brain damage markers in spinal fluid

Two-photon microscopy technique tracks calcium levels in mice neurons

New president elected for the Foundation for Informed Medical Decision Making non-profit organization

Combined therapy for acute leukemia shows promising results

Low-carbohydrate and high-protein diet increases the risk for atherosclerosis and impaired blood vessels

Medical students experience life inside nursing home

Curemark Founder delivers Industry Keynote address at Epigenomics Conference 2009

Research study links partial epilepsy to the disruption of brain development during early childhood

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News